ReDIB offers the scientific community access to its 16 essential imaging facilities and 49 biomedical/biological technologies, offering a wide range of imaging studies, from molecular analysis to cellular studies and acquisitions of regions or whole bodies in experimental animals and humans.
On April 1, the first Competitive Open Access call of 2025 (REDIB 2501) will launch. This Call allows national and international researchers to access cutting-edge technologies and services in clinical and preclinical biomedical imaging at attractive prices and with logistical advantages. Furthermore, they will have access to expert staff who will provide the necessary support to maximize the results of their research project, with personalized guidance in all aspects, from study design to image capture and analysis. Applications are submitted through a simple access protocol, and all studies are performed in certified facilities, which guarantee the quality and reproducibility of the data obtained.
Distributed Biomedical Imaging Network